Allurion Technologies, Inc. Fair Value Adjustment of Warrants
Allurion Technologies, Inc. (ALUR) reported Fair Value Adjustment of Warrants of -$4.32 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-05-15
- Allurion Technologies, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$4.32M.
- Allurion Technologies, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$3.59M.
- Allurion Technologies, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$1.48M.
- Allurion Technologies, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was -$2.06M.
- Allurion Technologies, Inc. fair value adjustment of warrants for fiscal 2025 was -$12.80M.
- Allurion Technologies, Inc. fair value adjustment of warrants for fiscal 2024 was -$17.02M.
- Allurion Technologies, Inc. fair value adjustment of warrants for fiscal 2023 was -$8.36M, a 1118.76% decline from fiscal 2022.
- Allurion Technologies, Inc. fair value adjustment of warrants for fiscal 2022 was $821.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$4.32M 10-Q · filed 2026-05-15 | -$7.91M derived: sum of 2 quarters · filed 2026-05-15 | -$9.39M derived: sum of 3 quarters · filed 2026-05-15 | -$11.46M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$5.07M derived: sum of 2 quarters · filed 2026-03-30 | -$7.13M derived: sum of 3 quarters · filed 2026-03-30 | -$12.80M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$1.48M 10-Q · filed 2025-11-17 | -$3.55M derived: sum of 2 quarters · filed 2025-11-17 | -$9.21M 10-Q · filed 2025-11-17 | -$12.03M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$2.06M 10-Q · filed 2025-08-19 | -$7.73M 10-Q · filed 2025-08-19 | -$10.55M derived: sum of 3 quarters · filed 2026-05-15 | -$20.25M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$5.67M 10-Q · filed 2026-05-15 | -$8.48M derived: sum of 2 quarters · filed 2026-05-15 | -$18.19M derived: sum of 3 quarters · filed 2026-05-15 | -$19.56M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$12.52M derived: sum of 2 quarters · filed 2026-03-30 | -$13.89M derived: sum of 3 quarters · filed 2026-03-30 | -$17.02M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$9.70M 10-Q · filed 2025-11-17 | -$11.08M derived: sum of 2 quarters · filed 2025-11-17 | -$14.21M 10-Q · filed 2025-11-17 | -$20.39M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$1.38M 10-Q/A · filed 2025-08-28 | -$4.51M 10-Q/A · filed 2025-08-28 | -$10.68M derived: sum of 3 quarters · filed 2025-08-28 | -$14.55M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | -$3.13M 10-Q/A · filed 2025-08-28 | -$9.31M derived: sum of 2 quarters · filed 2025-08-28 | -$13.17M derived: sum of 3 quarters · filed 2025-08-28 | -$12.97M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | -$6.17M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | -$10.04M derived: sum of 2 quarters · filed 2025-08-28 | -$9.84M derived: sum of 3 quarters · filed 2025-08-28 | -$8.36M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | -$3.87M 10-Q/A · filed 2025-08-28 | -$3.66M derived: sum of 2 quarters · filed 2025-08-28 | -$2.19M 10-Q/A · filed 2025-08-28 | -$1.27M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | $204.00K 10-Q/A · filed 2025-08-28 | $1.68M 10-Q/A · filed 2025-08-28 | $2.60M derived: sum of 3 quarters · filed 2025-08-28 | $2.53M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | $1.48M 10-Q/A · filed 2025-08-28 | $2.40M derived: sum of 2 quarters · filed 2025-08-28 | $2.33M derived: sum of 3 quarters · filed 2025-08-28 | |
| 2022-12-31 | $922.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $855.00K derived: sum of 2 quarters · filed 2025-08-28 | $821.00K 10-K/A · filed 2025-08-28 | |
| 2022-09-30 | -$67.00K 10-Q · filed 2023-11-14 | -$101.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$34.00K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |